1. A personal sensing technology enabled service versus a digital psychoeducation control for primary care patients with depression and anxiety: a pilot randomized controlled trial.
- Author
-
Stiles-Shields, Colleen, Reyes, Karen M., Lakhtakia, Tanvi, Smith, Shannon R., Barnas, Olga E., Gray, Elizabeth L., Krause, Charles J., Kruzan, Kaylee P., Kwasny, Mary J., Mir, Zara, Panjwani, Sameer, Rothschild, Steven K., Sánchez-Johnsen, Lisa, Winquist, Nathan W., Lattie, Emily G., Allen, Nicholas B., Reddy, Madhu, and Mohr, David C.
- Subjects
- *
MOBILE apps in education , *MENTAL illness , *QUALITY of life , *PHYSICAL mobility , *COGNITIVE therapy - Abstract
Background: Technology-enabled services (TES; clinical services that include both technology-driven [e.g., personal sensing technologies] and person-powered support elements) may address gaps in depression and anxiety treatments in healthcare settings. The current study: (1) developed a TES tailored for Primary Care patients with depression and/or anxiety, and (2) conducted a pilot randomized controlled trial to assess the efficacy of the TES compared to a digital psychoeducation control app. Methods: Participants were randomized to either: (1) TES: the "Vira" smartphone app (Ksana Health Inc.), informed by behavioral activation and using passive sensing technology to provide behavioral "insights" and target behaviors associated with mental health symptoms, alongside lay-provider coaching, or (2) Control: the Mood Education mobile app (ME), containing static psychoeducational resources designed to target mental health symptoms. Both apps collected usage data. Participants completed assessments on depression (PHQ-9), anxiety (GAD-7), health-related quality of life (PedsQL), and engagement (TWEETs) at baseline, mid-treatment (week 4), end-of-treatment (week 8), and post-treatment (week 12). Results: Participants (N = 130) were randomized to receive either the TES (Vira; Mage= 30) or ME (Mage= 33). Linear mixed-effects models determined significant improvements in PHQ-9 and GAD-7 scores for participants across both conditions (ps < 0.001). There was no interactive effect of intervention and time for the PHQ-9 (p =.90) nor the GAD-7 (p =.49). Adjusting for baseline differences and randomization strata, TES participants reported a greater change in a quality of life rating of Physical Functioning (PedsQL) across time (p =.018). TES participants also reported higher levels of engagement and demonstrated higher app usage. However, adjusting for baseline symptom severity, neither app usage nor coach interaction frequency moderated outcomes (ps ≥ 0.2). Conclusions: While the TES demonstrated superior engagement, improvements in depressive and anxious symptoms for both conditions speak to the potential benefit of both TES and low-intensity psychoeducation treatments in care settings. Future research is needed to better understand which patients might differentially benefit from TESs and broader personal sensing technologies over low-intensity treatments. Trial registration: ClinicalTrials.gov NCT05406791. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF